Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-5,684
Closed -$684K – 550
2026
Q1
$684K Hold
5,684
– – 0.05% 302
2025
Q4
$598K Hold
5,684
– – 0.05% 255
2025
Q3
$477K Hold
5,684
– – 0.04% 222
2025
Q2
$450K Sell
5,684
-6,100
-52% -$485K 0.06% 183
2025
Q1
$1.06M Sell
11,784
-1,248
-10% -$117K 0.13% 145
2024
Q4
$1.3M Buy
+13,032
New +$1.34M 0.14% 143
2017
Q1
– Sell
-12,576
Closed -$706K – 341
2016
Q4
$706K Buy
+12,576
New +$736K 0.07% 186

Other funds holding MRK

K2 Principal Fund's MRK Position: Q2 2026 in Review

K2 Principal Fund sold out of Merck (MRK) in Q2 2026, closing a stake of 5,684 shares — an estimated $684K sold.

K2 Principal Fund first reported a position in MRK in Q4 2016 and held it in 7 quarters. The position peaked at $1.3M in Q4 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • K2 Principal Fund reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • K2 Principal Fund sold 5,684 Merck shares in Q2 2026, an estimated $684K.
  • K2 Principal Fund first reported a position in Merck in Q4 2016 and held it in 7 quarters.
  • K2 Principal Fund's Merck position peaked at $1.3M in Q4 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on K2 Principal Fund's 13F filing for Q2 2026, filed 7 Aug 2026.